Skip to content

Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)

Ultrasound Dilution Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00920062
Enrollment
16
Registered
2009-06-15
Start date
2007-06-30
Completion date
2013-06-30
Last updated
2016-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recirculation, Venovenous Extracorporeal Membrane Oxygenation

Keywords

recirculation, ultrasound dilution, venovenous extracorporeal membrane oxygenation

Brief summary

This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurements determine the efficiency of support provided by venovenous extracorporeal membrane oxygenation. At the present time there are no other devices available to make recirculation measurements.

Detailed description

At the present time there are no devices available to measure recirculation in patients on venovenous extracorporeal membrane oxygenation. The study uses an external monitor, laptop computer, clamp on flowsensors and ultrasound dilution technology to measure blood flow. Measurements are made by injecting 0.5 - 1 ml/kg of sterile isotonic saline into the patient's extracorporeal circuit. The subject will be monitored throughout the measurements. The measurements will be coordinated with the regular care of the patient and their extracorporeal circuit.

Interventions

None listed

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Transonic Systems Inc.
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 21 Years
Healthy volunteers
No

Inclusion criteria

* Patients between 0 and 21 years of age * Patients receiving venovenous extracorporeal membrane oxygenation as treatment.

Exclusion criteria

* Patients over 21 years of age * Patients not receiving venovenous extracorporeal membrane oxygenation.

Design outcomes

Primary

MeasureTime frame
Recirculation measurements made in patients receiving venovenous extracorporeal membrane oxygenation.Duration of venovenous extracorporeal membrane oxygenation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026